Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Viridian Therapeutics Inc. buy BiotechBee

Viridian Therapeutics Inc.
Start price
€22.20
07.09.22 / 70%
Target price
€40.00
31.05.25
Performance (%)
14.41%
End price
€25.40
05.05.23
Summary
This prediction ended on 05.05.23 with a price of €25.40. The prediction had a final performance of 14.41%. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Viridian Therapeutics Inc. - - - -
iShares Core DAX® 1.803% 0.496% 18.553% 66.100%
iShares Nasdaq 100 0.429% -0.410% 8.908% 102.921%
iShares Nikkei 225® 0.708% -3.799% 12.088% 42.472%
iShares S&P 500 0.288% -0.218% 3.736% 63.299%

According to BiotechBee what are the pros and cons of Viridian Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Viridian Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 14.41%
Target price 40.000
Change
Ends at 31.05.25

Buy mit Kursziel 40,0

BiotechBee 
0
Report Share
07.09.22
In the thread Trading Viridian Therapeutics Inc.
Prediction Buy
Perf. (%) 14.41%
Target price 40.000
Change
Ends at 31.05.25

Buy beendet

BiotechBee 
0
Report Share
05.05.23

Stopped prediction by BiotechBee for Viridian Therapeutics Inc.

buy
Viridian Therapeutics Inc.

Start price
Target price
Perf. (%)
€20.20
14.12.24
€23.00
31.12.26
-24.26%
18.02.25

Could be very worthwhile Investment >20% year
BiotechBee 
14.12.24 60%
buy
Viridian Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.40
16.09.24
€25.00
31.01.27
4.12%
14.12.24

Could be very worthwhile Investment >20% year
BiotechBee 
16.09.24 70%